14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 6 May 2024

Trading levels for EXAS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 62.33 2.96 %
R2 61.55 1.67 %
R1 61.07 0.87 %
Current price: 60.54
Support S1 59.50 -1.72 %
S2 59.02 -2.52 %
S3 58.23 -3.81 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 73.74 21.80 %
R2 72.95 20.50 %
R1 69.06 14.07 %
Current price 60.54
Support S1 59.49 -1.73%
S2 57.53 -4.97%
S3 56.90 -6.01%

EXAS Predictions History

3 years ago
JS predicted that EXAS for 2020-12-23 is going $141.40 (0.28%)

3 years ago
AntonioCariello predicted that EXAS for 2020-12-23 is going

Rank:

3 years ago
JS predicted that EXAS for 2020-11-18 is going $112.78 (0.37%)

3 years ago
David.Pierce.8003 predicted that EXAS for 2020-11-18 is going

Rank:

3 years ago
IDo Ron predicted that EXAS for 2020-11-18 is going

Rank:

4 years ago
JS predicted that EXAS for 2020-02-26 is going $89.75 (11.13%)

4 years ago
Hongbomberger141649 predicted that EXAS for 2020-02-26 is going

Rank:

4 years ago
2poJeff predicted that EXAS for 2020-02-26 is going $84.75 (-2.06%)

4 years ago
JS predicted that EXAS for 2020-02-24 is going $98.89 (3.48%)

4 years ago
JS predicted that EXAS for 2019-12-30 is going $93.07 (1.31%)

Click to get the best stock tips daily for free!

About EXACT Sciences Corporation

EXACT Sciences Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype Test, a tissue test delivering tumor profiling to aid th... EXAS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT